Emergent Biosolutions (NY: EBS )
3.190 -0.070 (-2.15%) Streaming Delayed Price Updated: 1:12 PM EDT, Sep 25, 2023 Add to My Watchlist
Press Releases about Emergent Biosolutions
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
February 27, 2023
Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
November 14, 2022
Emergent partners with the Armed Forces Research Institute of Medical Sciences for its capabilities in Chikungunya virus surveillance and field studies
Emergent BioSolutions Reports Financial Results For Third Quarter 2022
November 08, 2022
Shuman, Glenn & Stecker Investigates Emergent BioSolutions, Inc.
September 21, 2021
Via Business Wire
FINAL DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 21, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.